Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antisense oligonucleotides as antiviral agents.

¹Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545.

Trends in Biotechnology

|May 1, 1992

Summary

Antisense oligonucleotides offer a promising new approach to antiviral therapies. Their specific design targets viral nucleic acids, presenting an advantage over conventional drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis.

British journal of cancer·2025

Same author

Dynamic versus fixed cerebral perfusion pressure targets in paediatric traumatic brain injury: a STARSHIP analysis.

EClinicalMedicine·2025

Same author

Stereoelectroencephalography (SEEG)-guided insula resections: is it "Reily" worth it?

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2024

Same author

What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists' perceptions on endpoints, benefit, price, and value of cancer drugs.

ESMO open·2024

Same author

Adopting prospective antimicrobial stewardship (AMS) practice in high-risk immunosuppressed groups: an urgent call to action in the era of antimicrobial resistance (AMR).

JAC-antimicrobial resistance·2024

Same author

Ultra-low oxygen, liquid sample cell for in situ synchrotron-based small-wide angle scattering (SAXS-WAXS).

The Review of scientific instruments·2023

Area of Science:

Biochemistry
Molecular Biology
Drug Discovery

Background:

Conventional antiviral drugs often target proteins with unknown structures.
Antisense oligonucleotides (ASOs) represent a potential alternative therapeutic strategy.

Purpose of the Study:

To explore the potential of ASOs as antiviral agents.
To highlight the advantages of ASO rational design in antiviral therapy.

Main Methods:

Rational design of oligonucleotides for specific nucleic acid sequence binding.
Review of current progress in ASO development for antiviral applications.

Main Results:

ASOs can be rationally designed to bind specific nucleic acid sequences.
This specificity offers an advantage over conventional antiviral drugs.

Conclusions:

Antisense oligonucleotides show significant promise as a new class of antiviral chemotherapeutics.
The rational design of ASOs facilitates targeted antiviral therapy.

Related Experiment Videos